Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Wave Life Sciences, Duchenne muscular dystrophy
Wave Life Sciences’ stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trial
Biotech reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne muscular dystrophy.
Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug
Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping. DMD is a genetic disease that causes progressive muscle weakness and degeneration caused by a mutation in the dystrophin gene.
Wave Life Sciences gains on data for Duchenne therapy
Wave Life Sciences (WVE) stock rises on positive interim data from a Phase 2 trial for for WVE-N531, a therapy for Duchenne muscular dystrophy (DMD). Read more here.
Wave Life Sciences Shares Climb Premarket on Duchenne Study Data
Shares of Wave Life Sciences rose more than 10% in premarket trading Tuesday after the clinical-stage biotechnology company reported positive interim data from a mid-stage study of its WVE-N531 drug candidate in the neuromuscular genetic disease Duchenne muscular dystrophy.
23h
Formula 1 Precision Meets Life Sciences: How IoT Is Accelerating Innovation In Manufacturing
Just as F1 teams rely on real-time data to optimize performance, IoT is enabling life sciences manufacturers to achieve new ...
GlobeSt.com
1d
Life Sciences Challenged By Overbuilding
Former Fed chairman Alan Greenspan coined the phrase "irrational exuberance" to describe the risk of unduly escalated asset ...
The Business Journals
2d
Increased vacancy rates don't tell the full story when it comes to life sciences in Chicago
Here's why Chicago is expected to be a growth spot for
life
sciences
in the coming years. Chicago is expected to be a ...
GlobalData on MSN
22h
ReAlta Life Sciences doses first patient in trial of graft-versus-host disease drug
The primary goals of the study are to evaluate the safety and overall response rate in patients who are given RLS-0071.
Hartford Business
17h
5 life sciences companies expanding in CT
Five life sciences companies are expanding their operations in Connecticut, including several that are leasing space in the ...
Business Eye on MSN
1d
Irish Life Sciences Start-Up Secures €280,000 Enterprise Ireland Funding
Marama Labs, a life-sciences instrumentation start-up, has secured €280,000 in funding from Enterprise Ireland to fund the ...
21h
MJH Life Sciences® shares exclusive insights from the CEOs of America’s most dynamic emerging biotech organizations
By engaging with some of the most influential executives in the industry and the many organizations that advocate for them, the series will provide valuable perspectives on the evolving landscape of ...
22h
Axtria is Revolutionizing Field Force Management for Life Sciences and Pharma Companies
Life Sciences and Pharma industry leaders are turning to Axtria for cutting-edge solutions that boost field force ...
FiercePharma
1d
Rejuveron Life Sciences rejuvenates as Centenara Labs
Swiss anti-aging biotech Rejuveron is seeking its rejuvenation as it morphs into Centenara Labs. | Swiss anti-aging biotech ...
Medicine Buffalo
14h
UB CAT announces R&D collaboration awards to eight life sciences companies
Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback